• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

减少伤害医疗保健:从非主流平台到主流平台?

Harm reduction healthcare: from an alternative to the mainstream platform?

机构信息

School of Public Health & Community Medicine, University of New South Wales, Sydney, Australia.

出版信息

Int J Drug Policy. 2010 Mar;21(2):131-3. doi: 10.1016/j.drugpo.2010.01.001. Epub 2010 Jan 21.

DOI:10.1016/j.drugpo.2010.01.001
PMID:20092999
Abstract

Despite a plethora of health-related problems, access to primary healthcare is often limited for drug users (DUs). Many seek care at emergency departments and tertiary hospitals because of late presentation of illness. The costs to both DUs and the health system are such that harm reduction based healthcare centres (HRHCs) have been established in various settings and utilising a variety of models. These provide a range of medical and sometimes social services, in one, integrated, low-threshold facility, including (or closely linked with) programs such as needle syringe provision. In some countries these HRHCs are becoming an alternative healthcare system for DUs. However, the need to provide such services on a broad, public health scale, in a sustainable, cost-effective manner, raises the question as to whether such programmes should be mainstreamed. This commentary provides insights on advantages and disadvantages to mainstreaming HRHCs, and approaches and barriers to achieving this. Two approaches suggest themselves: (i) providing harm reduction services through the regular healthcare system, or (ii) more closely integrating HRHCs with mainstream services. Funding and stigma are major barriers to mainstreaming. Diverse national policies towards DUs, healthcare systems and contexts, necessitate different approaches. Because of the various barriers to mainstreaming, any steps towards mainstreaming should be taken whilst maintaining the option of continuing the current targeted harm reduction services.

摘要

尽管存在大量与健康相关的问题,但吸毒者(DU)往往难以获得基本医疗保健。由于疾病晚期出现,许多人到急诊部门和三级医院寻求治疗。DU 和卫生系统的成本如此之高,以至于在各种环境中建立了基于减少伤害的医疗中心(HRHC),并利用各种模式。这些中心在一个综合、低门槛的设施中提供一系列医疗服务,有时还提供社会服务,包括(或与)诸如提供针具注射器等计划紧密相关。在一些国家,这些 HRHC 正在成为 DU 的替代医疗系统。然而,需要以可持续、具有成本效益的方式广泛提供此类服务,引发了一个问题,即此类方案是否应成为主流。本评论提供了将 HRHC 纳入主流的优势和劣势的见解,以及实现这一目标的方法和障碍。有两种方法可供选择:(i)通过常规医疗保健系统提供减少伤害服务,或(ii)更紧密地将 HRHC 与主流服务相结合。资金和耻辱感是纳入主流的主要障碍。各国对 DU、医疗保健系统和背景的不同政策,需要采取不同的方法。由于主流化的各种障碍,在朝着主流化迈出任何步骤的同时,应保留继续提供当前有针对性的减少伤害服务的选择。

相似文献

1
Harm reduction healthcare: from an alternative to the mainstream platform?减少伤害医疗保健:从非主流平台到主流平台?
Int J Drug Policy. 2010 Mar;21(2):131-3. doi: 10.1016/j.drugpo.2010.01.001. Epub 2010 Jan 21.
2
Improving health and social care relationships for harm reduction.改善健康与社会关怀关系以减少伤害。
Int J Drug Policy. 2007 May;18(3):194-203. doi: 10.1016/j.drugpo.2006.07.005. Epub 2006 Sep 7.
3
Moving from a project to programmatic response: scaling up harm reduction in Asia.从项目到计划性应对:在亚洲扩大减少伤害。
Int J Drug Policy. 2010 Mar;21(2):134-6. doi: 10.1016/j.drugpo.2009.12.004. Epub 2010 Jan 15.
4
Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.整合多种针对注射吸毒者丙型肝炎预防和护理的项目及政策方法:一种综合方法。
Int J Drug Policy. 2007 Oct;18(5):417-25. doi: 10.1016/j.drugpo.2007.01.013. Epub 2007 Feb 20.
5
Public stigma in health and non-healthcare students: attributions, emotions and willingness to help with adolescent self-harm.健康专业与非健康专业学生的公众污名:对青少年自我伤害的归因、情绪及帮助意愿
Int J Nurs Stud. 2009 Jan;46(1):107-18. doi: 10.1016/j.ijnurstu.2008.08.014. Epub 2008 Oct 28.
6
Organizational and client determinants of cost in outpatient substance abuse treatment.门诊药物滥用治疗中成本的组织和客户决定因素。
J Ment Health Policy Econ. 2007 Mar;10(1):3-13.
7
Drug use, harm reduction, and health policies in Argentina: obstacles and new perspectives.阿根廷的药物使用、减少伤害与健康政策:障碍与新视角
Clin Infect Dis. 2003 Dec 15;37 Suppl 5:S366-71. doi: 10.1086/377564.
8
'Individual' harms, Community 'harms': reconciling Indigenous values with drug harm minimisation policy.个体“伤害”、社区“伤害”:调和原住民价值观与药物伤害最小化政策
Drug Alcohol Rev. 2006 May;25(3):219-25. doi: 10.1080/09595230600644681.
9
Harm reduction programmes in the Asia--Pacific Region.亚太地区的减少伤害计划。
Drug Alcohol Rev. 2008 Jan;27(1):95-8. doi: 10.1080/09595230701711173.
10
Global strategy for further reducing the leprosy burden and sustaining leprosy control activities 2006-2010. Operational guidelines.2006 - 2010年进一步减轻麻风病负担和持续开展麻风病防治活动全球战略。操作指南。
Lepr Rev. 2006 Sep;77(3):IX, X, 1-50.

引用本文的文献

1
Barriers and facilitators to primary care engagement for people who inject drugs: A systematic review.注射吸毒者参与初级保健的障碍与促进因素:一项系统综述。
J Nurs Scholarsh. 2023 May;55(3):605-622. doi: 10.1111/jnu.12863. Epub 2022 Dec 8.
2
Prevalence and Correlates of Sex Selling and Sex Purchasing among Adults Seeking Treatment for Cocaine Use Disorder.寻求可卡因使用障碍治疗的成年人中卖淫和嫖娼的流行情况及其相关因素。
Subst Use Misuse. 2021;56(14):2229-2241. doi: 10.1080/10826084.2021.1981391. Epub 2021 Sep 24.
3
Characterizing Health Care Access among Cisgender Female Sex Workers with Substance Use Histories in Baltimore, Maryland.
描述马里兰州巴尔的摩市有药物使用史的跨性别女性性工作者的医疗保健获取情况。
J Health Care Poor Underserved. 2021;32(3):1584-1603. doi: 10.1353/hpu.2021.0151.
4
"Beyond Safer Injecting"-Health and Social Needs and Acceptance of Support among Clients of a Supervised Injecting Facility."超越更安全注射" - 监督注射设施使用者的健康和社会需求以及对支持的接受程度。
Int J Environ Res Public Health. 2019 Jun 7;16(11):2032. doi: 10.3390/ijerph16112032.
5
Life after opioid-involved overdose: survivor narratives and their implications for ER/ED interventions.阿片类药物过量后生活:幸存者的叙述及其对急诊室/ED 干预的意义。
Addiction. 2019 Aug;114(8):1379-1386. doi: 10.1111/add.14608. Epub 2019 Apr 11.
6
Factors associated with knowledge of a Good Samaritan Law among young adults who use prescription opioids non-medically.在非医疗用途使用处方阿片类药物的年轻人中,与《好撒玛利亚人法》知晓情况相关的因素。
Harm Reduct J. 2016 Jul 26;13(1):24. doi: 10.1186/s12954-016-0113-2.
7
Compulsory maintenance treatment program amongst Iranian injection drug users and its side effects.伊朗注射吸毒者的强制维持治疗方案及其副作用。
Int J High Risk Behav Addict. 2014 Sep 17;3(4):e21765. doi: 10.5812/ijhrba.21765. eCollection 2014 Dec.
8
A policy-maker's perspective on 'ECDC and EMCDDA guidance: prevention and control of infectious diseases among people who inject drugs'.政策制定者对“欧洲疾病预防控制中心和欧洲药物滥用监测中心指南:注射吸毒者中传染病的预防与控制”的看法
BMC Infect Dis. 2014;14 Suppl 6(Suppl 6):S11. doi: 10.1186/1471-2334-14-S6-S11. Epub 2014 Sep 19.
9
Key challenges in providing services to people who use drugs: The perspectives of people working in emergency departments and shelters in Atlantic Canada.为吸毒者提供服务的主要挑战:加拿大大西洋地区急诊科和庇护所工作人员的观点。
Drugs (Abingdon Engl). 2014 Jun;21(3):244-253. doi: 10.3109/09687637.2013.870534.
10
Harm reduction services as a point-of-entry to and source of end-of-life care and support for homeless and marginally housed persons who use alcohol and/or illicit drugs: a qualitative analysis.减少伤害服务作为无家可归和住房不稳定的酒精和/或非法药物使用者临终关怀和支持的切入点和来源:定性分析。
BMC Public Health. 2012 May 17;12:312. doi: 10.1186/1471-2458-12-312.